Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013LEARN MORE>
Actavis Completes Forest Laboratories Acquisition
>Go!

News

Keyword Search
03.17.2015
Actavis Announces Michael R. Gallagher and Peter J. McDonnell to Join Board of Directors
03.17.2015
Actavis Completes Allergan Acquisition
03.16.2015
Actavis Receives FDA Approval for VIIBRYD® (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose
03.16.2015
European Commission Clears Actavis' Pending Acquisition of Allergan
03.13.2015
Actavis Receives FDA Approval of SAPHRIS® for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder
<>
ELECTRONIC ENROLLMENT